Related Experiment Video
Updated: May 25, 2025
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia
Bram M Weijs1, Reindert F Oostveen, Jordan M Kraaijenhof
1Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Purpose Of Review:
The aim of this review is to examine recent advancements in RNA-targeted therapies for the management of severe hypertriglyceridemia (sHTG) and prevention of sHTG-associated acute pancreatitis.
Recent Findings:
Recent developments in RNA-targeted therapies, aimed at inhibiting apolipoprotein C-III (apoC-III), have demonstrated substantial and sustained reductions in triglyceride levels. Novel therapies, including antisense oligonucleotides (ASOs) and small interfering RNA (siRNA), such as volanesorsen, olezarsen, and plozasiran, have shown promising results in recent trials. These therapies not only effectively lower plasma triglyceride levels but also significantly reduce the incidence of acute pancreatitis.
Summary:
SHTG is a high-burden metabolic disorder that is associated with a significantly increased incidence and severity of acute pancreatitis. Traditional lifestyle interventions and conventional therapies, including fibrates and n-3 fatty acids, often provide only modest reductions in triglycerides and fail to prevent sHTG-associated acute pancreatitis. The emergence of novel and targeted RNA-therapies represents a potential breakthrough in the management of sHTG and acute pancreatitis prevention.
Insights
New RNA-targeted therapies show significant promise in lowering triglyceride levels and preventing acute pancreatitis in patients with severe hypertriglyceridemia. These advanced treatments offer a breakthrough for managing this metabolic disorder.
Area of Science:
- Biochemistry
- Genetics
- Pharmacology
Background:
- Severe hypertriglyceridemia (sHTG) is a serious metabolic disorder linked to increased acute pancreatitis risk.
- Conventional treatments like fibrates and n-3 fatty acids offer limited triglyceride reduction and pancreatitis prevention.
- Apolipoprotein C-III (apoC-III) plays a key role in triglyceride metabolism.
Purpose of the Study:
- To review recent progress in RNA-targeted therapies for severe hypertriglyceridemia.
- To evaluate the efficacy of these therapies in preventing acute pancreatitis.
- To highlight novel therapeutic strategies for sHTG management.
Main Methods:
- Review of recent clinical trials and scientific literature.
- Focus on RNA-targeted therapies inhibiting apolipoprotein C-III (apoC-III).
- Analysis of therapies including antisense oligonucleotides (ASOs) and small interfering RNA (siRNA).
Main Results:
- RNA-targeted therapies, including ASOs and siRNAs (e.g., volanesorsen, olezarsen, plozasiran), achieve substantial and sustained triglyceride reductions.
- These novel therapies significantly decrease the incidence of acute pancreatitis in sHTG patients.
- Promising clinical trial results demonstrate the efficacy of inhibiting apoC-III.
Conclusions:
- RNA-targeted therapies represent a significant advancement in managing sHTG.
- These therapies offer a more effective approach to preventing acute pancreatitis compared to traditional methods.
- Targeted RNA-based treatments hold potential as a breakthrough for sHTG and associated pancreatitis.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents